Physician profile
Edward B Eigner
NPI 1952394470
$3,945.50
in general payments reported to CMS, 2019-2025
20 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $1,996 · 2021: $642 · 2022: $414 · 2023: $222 · 2024: $17.85 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,852.90 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $434.83 | 2019-2022 | |
| Boston Scientific Corporation | $414.17 | 2019-2025 | Rezum Generator |
| Progenics Pharmaceuticals, INC. | $355.32 | 2021-2023 | Pylarify |
| Procept Biorobotics Corporation | $149.45 | 2025 | |
| Urogen Pharma, INC. | $124.76 | 2021 | |
| Sumitomo Pharma America, INC. | $122.35 | 2023 | Orgovyx |
| Medtronic, INC. | $70.21 | 2021 | |
| Astellas Pharma US INC | $63.08 | 2021-2023 | Veozah |
| Myovant Sciences INC. | $61.09 | 2021 | |
| 180 Medical, INC. | $60.70 | 2019-2023 | |
| Teleflex LLC | $48.12 | 2021-2023 | Urolift |
| Janssen Biotech, INC. | $41.32 | 2021 | |
| Myriad Genetic Laboratories, INC. | $40.34 | 2021-2022 | |
| Allergan, INC. | $26.95 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $21.64 | 2023 | |
| Abbvie INC. | $17.85 | 2024 | |
| Olympus America INC. | $16.52 | 2022 | |
| Merck Sharp & Dohme LLC | $12.30 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Eigner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.